Part of Liberty Latin America This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our strategies, priorities and objectives, financial and operational performance, growth expectations; our digital strategy, product innovation and commercial plans and projects; expectations on demand for connectivity in the region; the transaction with Tigo Costa Rica; the Boost migration; the recovery of our Puerto R ...

GENCO SHIPPING & TRADING LIMITED Q1 2025 Earnings Presentation May 8th, 2025 Forward Looking Statements "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995 This presentation contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements use words such as "anticipate," "budget," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of simil ...

GRIFFON OVERVIEW Copyright © 2025 Griffon Corporation. All rights reserved. Q1 FY25 INVESTOR PRESENTATION FEBRUARY 2025 Compelling opportunity for shareholder value creation supported by operating performance, deleveraging and capital allocation priorities $2.6B $528M $3.5B 20% $1.3B 5,160 Revenue Adj. EBITDA Market Cap1 Adj. EBITDA Margin Net debt Employees B R E A K D O W N B Y O P E R A T I N G S E G M E N T CPP 39% Adjusted EBITDA (excl. unallocated) ($millions) Revenue U.S. 82% Int'l 18% $503 $85 CPP H ...

Q1 2025 Supplemental Materials May 8, 2025 February X, 2025 Disclosures and Definitions Non-GAAP Financial Measures This presentation includes certain non-GAAP financial measures in addition to financial measures presented in accordance with U.S. GAAP. These non-GAAP financial measures are in addition to, and not a substitute for or superior to, measures of financial performance prepared in accordance with U.S. GAAP. See pages 19-33 for a reconciliation of the non-GAAP financial measures to their most compa ...

Investor Presentation INVESTOR PRESENTATION May 2025 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL MEASURES This presentation contains, and our other communications may contain, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements, written, oral or o ...

First Quarter 2025 Financial Results and Operational Highlights May 8, 2025 © 2025 NOVAVAX. All rights reserved. Cautionary Note Regarding Forward-Looking Statements This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. These forward-looking statements address various matters ...

First Quarter 2025 Financial Results MKS Instruments, Inc. May 8, 2025 Safe Harbor for Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of MKS Instruments, Inc. ("MKS," the "Company," "our," or "we"). These statements are only pred ...

First Quarter 2025 Results Earnings Presentation Important Disclosures CAUTIONARY STATEMENT REGARDING FINANCIAL AND OPERATING PROJECTIONS All financial and operating projections, forecasts or estimates about or relating to the Company included in this document, including statements regarding pro-forma valuation and ownership, have been prepared based on various estimates, assumptions and hypothetical scenarios. Forecasts and projections of financial performance, valuation and operating results are, by natur ...

WELCOME TO THE Q1 2025 EARNINGS CALL May 8, 2025 © 2025 Montrose Environmental Group, Inc. • Proprietary and Confidential 2 Key Updates OPERATING CASH FLOW $5.5M $27.5M Increase over Q1 2024 REVENUE $177.8M 14.5% Increase over Q1 2024 CONSOLIDATED ADJUSTED EBITDA1 $19.0M 10.7% of Revenue © 2025 Montrose Environmental Group, Inc. • Proprietary and Confidential 4 • • • • • • • © 2025 Montrose Environmental Group, Inc. • Proprietary and Confidential 5 ✓ • • ✓ ✓ • ✓ ✓ ✓ ✓ • • ✓ • Consolidated Adjusted EBITDA1 R ...

3 Royalty Pharma plc Q1 2025 Financial Results May 8, 2025 2 Forward Looking Statements & Non-GAAP Measures This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this presentation unless s ...